查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363922

全球沙门氏菌检测与治疗市场 2023-2030

Global Salmonella Testing and Treatment Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 115 Pages | 商品交期: 2-3个工作天内

价格

预计在预测期内（2023-2030年），全球沙门氏菌检测和治疗市场将以 7.5% 的复合年增长率成长。沙门氏菌是一种影响肠道的细菌性疾病。沙门氏菌通常生活在动物和人类肠道中，并透过粪便排出。人类最常透过受污染的水或食物而被感染。食物感染患者数量的增加是支持市场成长的主要因素。据农业环境和农村事务部称，已知沙门氏菌菌株（血清型）超过 2,500 种，其中大多数很少引起疾病。

此外，某些菌株，例如肠炎沙门氏菌和鼠伤寒沙门氏菌，可能会引起人类疾病。因此，人们和政府预防沙门氏菌感染的意识不断增强，是推动全球沙门氏菌检测和治疗市场的另一个因素。例如，2003年12月，议会和理事会关于控製沙门氏菌的条例，确保采取适当和有效的措施，在生产、加工和分销的所有相关阶段检测和控製沙门氏菌和其他人畜共患病病原体，以减少其流行率以及它们对公共健康构成的风险。

目录

第 1 章：报告摘要

  • 目前行业分析及成长潜力展望
  • 研究方法和工具
  • 市场区隔
    • 按细分
    • 按地区

第 2 章：市场概述与见解

  • 报告范围
  • 分析师见解和当前市场趋势
    • 主要发现
    • 建议
    • 结论

第 3 章：竞争格局

  • 主要公司分析
  • Abbott
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • Eiken Chemical Co., Ltd.
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • GlaxoSmithKline
    • 概述
    • 财务分析
    • SWOT分析
    • 最近的发展
  • 关键策略分析

第 4 章：市场细分

  • 按测试方法分類的全球沙门氏菌测试和治疗市场
    • 基于文化的方法
    • 基于分子的方法
    • 免疫测定
  • 按样本类型分類的全球沙门氏菌检测和治疗市场
    • 食物
    • 水
    • 环境表面
  • 全球沙门氏菌检测与治疗市场（按应用）
    • 临床诊断
    • 食品安全检测
    • 兽医诊断

第 5 章：区域分析

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 义大利
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 世界其他地区

第 6 章：公司简介

  • 3M Co.
  • Becton, Dickinson, and Company
  • Biomerieux
  • Bio-Rad Laboratories, Inc.
  • Enzo Life Sciences, Inc.
  • Hardy Diagnostics
  • IDEXX Laboratories, Inc.
  • Merck KGaA
  • Mylab Discovery Solutions Pvt. Ltd.
  • PerkinElmer Inc.
  • Shimadzu Diagnostics Corp.
  • Thermo Fisher Scientific Inc.
Product Code: OMR2027707

Title: Global Salmonella Testing and Treatment Market Size, Share & Trends Analysis Report by Testing Method (Culture-based Methods, Molecular-based Methods, and Immunoassays), by Sample Type (Food, Water, and Environmental Surfaces), and by Application (Clinical Diagnostics, Food Safety Testing, and Veterinary Diagnostics)Forecast Period (2023-2030).

The global salmonella testing and treatment market is anticipated to grow at a CAGR of 7.5% during the forecast period (2023-2030). Salmonella is a bacterial disease that affects the intestinal tract. Salmonella bacteria typically live in animal and human intestines and are shed through stool (feces). Humans become infected most frequently through polluted water or food. The increasing number of patients suffering from food infection is the primary factor supporting the market growth. According to the Department of Agriculture, Environment and Rural Affairs, over 2,500 strains (serovars) of Salmonella are known most of which rarely cause disease.

Furthermore, certain strains, such as salmonella enteritidis and salmonella typhimurium, may cause human disease. Hence, the increasing awareness among people and government initiatives for the prevention of salmonella infection is another factor driving the salmonella testing and treatment market globally. For instance, in December 2003, Parliament and Council Regulation on the control of salmonella to ensure that proper and effective measures were taken to detect and control Salmonella and other zoonotic agents at all relevant stages of production, processing, and distribution, to reduce their prevalence and the risk they pose to public health.

Segmental Outlook

The global salmonella testing and treatment market is segmented on the testing method, sample type, and application. Based on the testing method, the market is sub-segmented into culture-based Methods, molecular-based Methods, and immunoassays. Based on sample type, the market is sub-segmented into food, water, and environmental surfaces. Further, based on application, the market is sub-segmented into clinical diagnostics, food safety testing, and veterinary diagnostics.

The Molecular-Based Methods Sub-Segment is Anticipated to Hold a Considerable Share of the Global Salmonella Testing and Treatment Market

Among the industry verticals, the molecular-based method sub-segment is expected to hold a considerable share of the global salmonella testing and treatment market. The segmental growth is attributed to the adoption of testing methods such as polymerase chain reaction (PCR), DNA, loop-mediated isothermal amplification (LAMP), Nucleic acid sequence-based amplification (NASBA), recombinase polymerase amplification (RPA) and whole-genome sequencing. For Instance, in March 2012, Abbott collaborated with Genetics Laboratory, Inc. (GenLab) on the development of a molecular diagnostic test that will be designed to rapidly detect microorganisms that cause orthopedic infections. Under the terms of the agreement, Abbott, in conjunction with GenLab, will develop and commercialize the new assay for use on the PLEX-ID™ automated microbial identification system.

Regional Outlook

The global salmonella testing and treatment market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Europe is anticipated to hold a prominent share of the market across the globe, European Union has specific regulations in place for Salmonella testing in various food categories, such as poultry and eggs, and also has a focus on food safety and implements strict regulations for ensuring the quality of food products.

The North America Region is Expected to Grow at a Significant CAGR in the Global Salmonella Testing and Treatment Market

Among all regions, the North America region is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to a high prevalence of food-borne illnesses in North America. According to the Centers for Disease Control and Prevention (CDC), the US estimates that Salmonella is responsible for 1.4 million infections, 26,500 hospitalizations, and 420 fatalities. With the creation of the Interagency Food Safety Analytics Collaboration (IFSAC) in 2011; CDC, the U.S. Food and Drug Administration (FDA), and the U.S. Department of Agriculture's Food Safety and Inspection Service (USDA-FSIS) agreed to improve data and methods used to estimate foodborne illness source attribution and provide timely estimates of the food sources of four priority foodborne pathogens: Salmonella, Escherichia coli O157, Listeria monocytogenes and Campylobacter.

Market Players Outlook

The major companies serving the salmonella testing and treatment market include Abbott, Eiken Chemical Co., Ltd., GlaxoSmithKline, 3M, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2017, Merck KGaA acquired Biocontrol to Strengthen its Position in food safety testing the global spotlight on the importance of food safety has grown given the increased incidents of outbreaks and recalls with foodborne diseases often caused by consuming a wide range of foods including undercooked meat, eggs, fresh produce and dairy products contaminated by Salmonella, Listeria, E. coli O157H7 and Campylobacter.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global salmonella testing and treatment market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Abbott
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Eiken Chemical Co., Ltd.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. GlaxoSmithKline
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Salmonella Testing and treatment Market by Testing Method
    • 4.1.1. Culture-Based Methods
    • 4.1.2. Molecular-Based Methods
    • 4.1.3. Immunoassays
  • 4.2. Global Salmonella Testing and treatment Market by Sample Type
    • 4.2.1. Food
    • 4.2.2. Water
    • 4.2.3. Environmental Surfaces
  • 4.3. Global Salmonella Testing and treatment Market by Application
    • 4.3.1. Clinical Diagnostics
    • 4.3.2. Food Safety Testing
    • 4.3.3. Veterinary Diagnostics

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. 3M Co.
  • 6.2. Becton, Dickinson, and Company
  • 6.3. Biomerieux
  • 6.4. Bio-Rad Laboratories, Inc.
  • 6.5. Enzo Life Sciences, Inc.
  • 6.6. Hardy Diagnostics
  • 6.7. IDEXX Laboratories, Inc.
  • 6.8. Merck KGaA
  • 6.9. Mylab Discovery Solutions Pvt. Ltd.
  • 6.10. PerkinElmer Inc.
  • 6.11. Shimadzu Diagnostics Corp.
  • 6.12. Thermo Fisher Scientific Inc.

LIST OF TABLES

  • 1. GLOBAL SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TESTING METHOD, 2022-2030 ($ MILLION)
  • 2. GLOBAL CULTURE-BASED METHOD FOR SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL MOLECULAR-BASED METHOD FOR SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL IMMUNOASSAYS FOR SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY SAMPLE TYPE, 2022-2030 ($ MILLION)
  • 6. GLOBAL SALMONELLA TESTING AND TREATMENT ON FOOD MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL SALMONELLA TESTING AND TREATMENT ON WATER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL SALMONELLA TESTING AND TREATMENT ON ENVIRONMENTAL SURFACES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. GLOBAL SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 10. GLOBAL SALMONELLA CLINICAL DIAGNOSTICS TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL SALMONELLA FOOD SAFTY TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL SALMONELLA VETERINARY DIAGNOSTICS TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. GLOBAL SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 14. NORTH AMERICAN SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TESTING METHOD, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY SAMPLE TYPE, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 18. EUROPEAN SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 19. EUROPEAN SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TESTING METHOD, 2022-2030 ($ MILLION)
  • 20. EUROPEAN SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY SAMPLE TYPE, 2022-2030 ($ MILLION)
  • 21. EUROPEAN SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 22. ASIA-PACIFIC SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 23. ASIA- PACIFIC SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TESTING METHOD, 2022-2030 ($ MILLION)
  • 24. ASIA- PACIFIC SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY SAMPLE TYPE, 2022-2030 ($ MILLION)
  • 25. ASIA- PACIFIC SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 26. REST OF THE WORLD SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY TESTING METHOD, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY SAMPLE TYPE, 2022-2030 ($ MILLION)
  • 28. REST OF THE WORLD SALMONELLA TESTING AND TREATMENT MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL SALMONELLA TESTING AND TREATMENT MARKET SHARE BY TESTING MODE, 2022 VS 2030 (%)
  • 2. GLOBAL CULTURE-BASED METHOD FOR SALMONELLA TESTING AND TREATMENT MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL MOLECULAR-BASED METHOD FOR SALMONELLA TESTING AND TREATMENT MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL MOLECULAR-BASED METHOD FOR SALMONELLA TESTING AND TREATMENT MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL SALMONELLA TESTING AND TREATMENT MARKET SHARE BY SAMPLE TYPE, 2022 VS 2030 ($ MILLION)
  • 6. GLOBAL SALMONELLA TESTING AND TREATMENT ON FOOD MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL SALMONELLA TESTING AND TREATMENT ON WATER MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL SALMONELLA TESTING AND TREATMENT ON ENVIRONMENTAL SURFACES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL SALMONELLA TESTING AND TREATMENT MARKET SHARE ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 10. GLOBAL SALMONELLA CLINICAL DIAGNOSTICS TESTING AND TREATMENT MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 11. GLOBAL SALMONELLA FOOD SAFTY TESTING AND TREATMENT MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 12. GLOBAL SALMONELLA VETERINARY DIAGNOSTICS TESTING AND TREATMENT MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 13. GLOBAL SALMONELLA TESTING AND TREATMENT MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 14. US SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. CANADA SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. UK SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. FRANCE SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. GERMANY SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. ITALY SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. SPAIN SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. REST OF EUROPE SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. INDIA SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. CHINA SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. JAPAN SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. SOUTH KOREA SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. REST OF ASIA-PACIFIC SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD SALMONELLA TESTING AND TREATMENT MARKET SIZE, 2022-2030 ($ MILLION)